1975.-The objectives of this study were to describe in greater detail the initial rise and spontaneous decline in acute hypoxic pulmonary vasoconstriction and to investigate a number of mechanisms that could have caused this secondary vasodilation. With the onset of isocapnic hypoxia (Pao, of 28, 44,  or 56 mmHg), pulmonary vascular resistances increased to maximum values at 3 min and then spontaneously declined toward control values. Pulmonary perfusion pressures rose to maxima at approximately 4 min and then also declined.
During severe hypoxic exposures (Pa o2 of 30-37 mmHg) this secondary vasodilation was found not to be due to beta-adrenergic-induced vasodilation, withdrawal of alpha-adrenergic-induced vasoconstriction, vasodilation caused by a sustained increase in pulmonary blood flow, latigue of the vascular smooth muscle contractile mechanism, or release of vasodilatory prostaglandins.
It is suggested that the decline in hypoxic pulmonary vasoconstriction may be due to an exhaustion of a chemical mediator, release of a pulmonary vasodi- in both awake and anesthetized dogs increases pulmonary arteria1 pressure and pulmonary vascular resistance (5, 17, 21, 23, 25, 27, 32) . However, investigators disagree on the time courses, with increases in pressure and/or resistance being reported variously as immediate or delayed, transient or sustained (15, 19, 28, 29 After hypoxia, the effectiveness of beta blockade was confirmed by the absence of a heart rate response to infusions of isoproterenol.
A&ha-rece@ar blockade. Alpha-adren .ergic blockade was used to determine whether stimulation of alpha receptors (vasoconstrictor) was involved in the pulmonary vascular responses to hypoxia. After control hypoxic exposures (8.5 % 0,) in eight dogs, alpha blockade was produced by intravenous infusion of phenoxybenzamine (Dibenzyline, 1 mg/kg).
Approximately 38 min (30-46 min) elapsed between the end of infusion and the start of the postblockade hypoxic exposure* The effectiveness of alpha blockade was confirmed by abolition of the systemic arterial pressor responses to infusions of norepinephrine (Levophed, ILglmin) -Beta-and alpha-receptor blockade. The efl'ect of the combination of beta and alpha blockade on the hypoxic response was investigated in another group of eight dogs. In six animals, phenoxybenzamine
(1 mg/kg) was administered first, followed by propranolol (2 mg/kg). In the remaining two animals, propranolol w phenoxybenzamine and *as administered first, followed then a second dose of propran bY 0101 (2 "g/kg).
The p u monary 1 vascular responses to hypoxia (8.5 5; 0,) were determined prior to and after the institution of both beta and alpha blockade.
Controlled pulmonary blood @I. 2). Dense blockade was produced with practolol as evidenced in six dogs by the nonresponsiveness of heart rate (8.3 % increase) to isoproterenol infusions compared to the increase (61.9 X,) observed prior to blockade.
Alpha-adrenergic blockade with phenoxybenzamine decreased pulmonary perfusion pressure both during normoxia and hypoxia (Pa9, = 3 1 mmHg), but the percent increase in perfusion pressure during hypoxia was similar to that prior to blockade (Table  1) . The cardiac output during normoxia was also reduced by phenoxybenzamine, but the relative increase during hypoxia (+38 "r,) was greater than that prior to blockade (+28 %)-The absolute hypoxiainduced increase in pulmonary vascular resistance was greater after alpha blockade, but blockade did not change the time course of the resistance response (Table 2) . Norepinephrine challenge after phenoxybenzamine demonstrated dense blockade of the systemic arterial pressor response in eight dogs, with no increase in pressure after blockade compared to a 35.4 % increase prior to blockade. When beta- (propranolol) and alpha-(phenoxybenzamine) adrenergic blockades were induced simultaneously, the time course and magnitude of the pulmonary vascular responses to hypoxia (Pao2 = 31 mmHg)
were similar to the preblockade responses and were almost identical to those seen with alpha blockade alone (Tables  1 and 2 ). Therefore, the decline in pulmonary vascular resistance was unaltered by comple, e chemical adrenergic blockade. Prevention of the usual rise in cardiac output during hypoxia by partia1 inferior vena caval obstruction resulted i n a less marked pulmonary pressor response to hypoxia (P a02 = 33 mmHg).
However, a spontaneous decline in pressure was still observed (Fig. 4, Table 1 ). Although the magnitude and time course of pulmonary vascular resistance were altered when cardiac output was controlled, a significant decline in resistance was still evident (Fig. 4, Table 2 ). In fact, between 10 and 20 min the fall in resistance was slightly more pronounced during inferior vena caval obstruction Since both pressure and resistance decreased with time, the secondary vasodilation cannot be attributed primarily to a sustained increase in pulmonary blood flow. Prostaglandin FI Ja administration during the normoxic control period increased pulmonary perfusion pressure 137 c;;': and pulmonary vascular resistance 111 %. After 20 min of hypoxia, when pressure and resistance had declined toward the normoxic control level, prostaglandin Fz, increased pressure 109 C;C: and resistance 123 % above the ZOmin hypoxia value, indicating that the pulmonary vessels were still capable of active constriction.
Indomethacin did not modify either the magnitude or the time course of the pulmonary vascular responses to hypoxia (Tables  1 and Z) , implying that prostaglandins (e.g., PGEI) are not involved in the spontaneous reversal of hypoxic vasoconstriction.
DISC LESION
The pulmonary vascular response to hypoxia in the dog appears to be both time and stimulus dependent.
With a given stimulus, the initial pulmonary pressor response declined with time. Also, at a given duration of hypoxia, the magnitude of the response varied with the intensity of the stimulus. The most severe hypoxic exposure did not evoke the greatest increase in pulmonary vascular resistance. Indeed, compared to moderate hypoxia, severe hypoxia evoked an increase that was smaller both in magnitude and duration.
The greatest percent increase in pulmonary vascular resistance occurred at an arterial oxygen tension of 44 mmHg.
In the isolated dog lung perfused at constant flow, Lloyd (18) f ound that a gas mixture containing no oxygen produced a smaller pressor response than one containing 5.8 % oxygen. Thus, it appears that in the dog there is probably an optimal arterial oxygen tension for producing a maximum increase in pulmonary vascular resistance. This dependence of the pressor response on the duration and severity of the hypoxic stimulus may explain the considerable variation in published reports far the dog (5, 7, 17, 19, 27, 29) .
The present observations confirm the recent report by Malik and Kidd (19) that the initial increase in pulmonary vascular resistance declines spontaneously during severe hypoxia.
However, the present data do not support their conclusions that 1) the decline in resistance was due entirely to an increased cardiac output with no decrease in pulmonary perfusion pressure or 2) that the increase in cardiac output was due to the respiratory alkalosis that accompanied hypoxia.
In the present study, after about 5 min of hypoxia, we observed a steady decline in pulmonary perfusion pressure, a finding previously reported (15). In addition, alkalosis was prevented by the addition of CO2 to the inspired air and therefore respiratory alkalosis could not account for either the increase in cardiac output or the fall in pulmonary vascular resistance during hypoxia. These discrepancies may have been due to the use of beagles by Malik and Kidd (19) and our use of mongrel dogs. In this laboratory six beagles studied during acute hypoxia yielded data similar to those obtained from the mongrel dogs. Perhaps the explanation for the discrepancies lies in the difierent altitudes of the two laboratories or in some unspecified methodological difference. A sustained increase in blood flow has been suggested to cause passive pulmonary vasodilation (l), either by vasodilating constricted vessels or by opening previously closed vascular channels.
Since the most rapid decline in pulmonary vascular resistance was accompanied by the greatest increase in cardiac output, the secondary vasodilation in this study may have been due to the increased pulmonary blood flow. However, when the hypoxia-induced increase in cardiac output was prevented by partial inferior vena caval obstruction the secondary vasodilation was still evident. In addition, if the attenuated resistance response were due solely to increased blood flow, then perfusion pressure should have increased.
The fall in perfusion pressure during sustained increased perfusion implies disproportionate opening of vascular channels, signifying a reversal of the pulmonary vasoconstrictor response. These findings suggest that the sustained increase in cardiac output observed during acute hypoxia was not the primary cause of the secondary vasodilation. However, it may have contributed to the reversal of pulmonary vascular resistance dented by experimen slightly as evlthe practolol and inferior v *ena caval obs truction ts, in which c ardiac output was reduced and the fall in resistance was attenuated.
Beta blockade has been shown to augment pulmonary vasoconstriction during hypoxia (26), suggesting that stimulation of Pz-vasodilator receptors may oppose hypoxic vasoconstriction.
Thus, an increased level of beta stimulation during hypoxia could be postulated to explain the spontaneous reversal of the hypoxia-induced increase in pulmonary vascular resistance observed in the present study.
However, beta blockade with propranolol had little effect on the measured circulatory responses to hypoxia, a result that has been noted previously (20) . Practolol, which presumably blocks pi-(cardiac) receptors, was more effective than propranolol in reducing the cardiac output response to hypoxia. Neither of the two beta-blocking agents prevented the spontaneous decline in pulmonary vascular resistance. Thus, beta-adrenergic stimulation does not account for the reversal of hypoxic vasoconstriction.
Since alpha-adrenergic stimulation has been implicated in mediating or augmenting hypoxic pulmonary vasoconstriction (2-4, 22), spontaneous withdrawal of alpha stimulation during hypoxia could cause a fall in pulmonary vascular resistance. However, neither the initial vasoconstriction nor the subsequent decline in pressure and resistance was altered by alpha blockade.
The results support the view that alpha-adrenergic mechanisms are not involved in the hypoxic response (7, 8, 12, 20, 24, 26) and that the decline in pulmonary hypertension is unrelated to alpha stimulation.
After the initial hypoxic vasoconstriction, maintenance of an elevated pulmonary arterial pressure and resistance requires sustained contraction of the vascular smooth muscle. Severe hypoxia may impair or fatigue the contractile mechanisms, resulting in relaxation of the constricted vessels. In the present study, the response of the pulmonary vascular smooth muscle to PGFza was not diminished during 20 min of hypoxia when pressure and resistance had fallen toward control levels. Thus, the pulmonary vascular contractile mechanisms appear to remain intact during hypoxia.
Indomethacin is a potent inhibitor of prostaglandin synthesis and was expected to prevent the formation, if any, of pulmonary vasodilators (e.g., PGEI) or pulmonary vasoconstrictors (e.g., PGFT,) during hypoxia. The failure of indomethacin to alter the magnitude or time course of the pulmonary vascular resistance during hypoxia suggests that prostaglandin synthesis is required neither in the initial hypoxic response nor in the spontaneous decline in resistance. The possibility that other vasodilators are released during hypoxia remains unexplored.
If a chemical substance mediates hypoxic vasoconstriction, then severe hypoxia may inhibit synthesis of the mediator, resulting in depletion of stores of the SU bstance, poss from the mast cell (11). H ypoxia woul d then release ibly the stored mediator and induce an initial maximal rise in pulmonary arterial pressure followed by a decline, similar to that observed in the present study. Until a mediator of hypoxic pulmonary hypertension is identified, such a proposed mechanism remains conjecture. Another possible mechanism of the secondary vasodilatation is myogenic stress relaxation. The smooth muscle of blood vessels, when stretched abruptly, shows a decay in tension (stress relaxation) that is proportional to the stress applied (9). Stress relaxation may be related to the efflux of intracellular calcium and may account for the secondary relaxation observed in systemic arteries after constriction with epinephrine, angiotensin, prostaglandin Fza, and vasopressin (13, 14 Pulmonary vascular responses to acute or chronic hypoxia vary widely from one species to another (10). In the present investigation we have shown that acute hypoxia produces a marked increase in pulmonary vascular resistance during the initial 5 min, but this response has largely disappeared after 20 min of hypoxia.
Furthermore, when the hypoxic stimulus is maintained for 4 wk, the dog does not develop chronic pulmonary hypertension (30). In contrast, chronic hypoxia produces sustained pulmonary hypertension in other species, including cattle, swine, and man (30). Therefore, the finding in the present study that acute hypoxic pulmonary hypertension is not sustained may be peculiar to the dog and may not apply to other species.
The present study has confirmed that there is a spontaneous reversal of hypoxic pulmonary vasoconstriction during
